Back to results
US 2020/0268703 A1Published application
Medicine for treating advanced or recurrent cancer patient being non-responsive or non-tolerant to standard chemotherapy and incurable and unresectable
AssigneesTakahito JOMORI, Hyogo College of Medicine
InventorsShojiro KIKUCHI, Mitsuru SASAKO, Hiroto MIWA, Hisashi SHINOHARA, Hiromitsu KISHIMOTO, Kazuma NOGUCHI, Takahito JOMORI
Life of this patent
Estimating the term…
Abstract
The present invention relates to a medicine for treating a patient with advanced or recurrent cancer which is non-responsive or non-tolerant to standard chemotherapy and incurable and unresectable, the medicine comprising propagermanium.
Claims13
-12. (canceled)
A method for treating a patient with advanced or recurrent cancer which is non-responsive or non-tolerant to standard chemotherapy and incurable and unresectable, the method comprising:
- administering propagermanium to the patient in need thereof.
Dependencies are inferred from the claim text.